Hepatocarcinogenesis and ceramide/cholesterol metabolism.
about
Modulation of Autophagy by Sorafenib: Effects on Treatment ResponseSerum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failureHydroxysteroid sulfotransferase SULT2B1b promotes hepatocellular carcinoma cells proliferation in vitro and in vivo.Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma.Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver.New insights into the effects of onion consumption on lipid mediators using a diet-induced model of hypercholesterolemiaSerum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients.V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.Potential for statins in the chemoprevention and management of hepatocellular carcinoma.Sphingolipid metabolic pathway: an overview of major roles played in human diseases.Network stratification analysis for identifying function-specific network layers.Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.Comments on "NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis".Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis.
P2860
Q26745320-9048628C-1D32-4FD2-906B-46B32503D635Q34066622-0C076D57-64BD-4011-B919-92F096999ACFQ34674259-1AD27FD7-BC8B-49F4-A7FB-AEC42AA767BAQ35608091-DBF8569C-8DD3-4F2F-BCBE-3440A7AEB590Q35884228-7DE01DC7-2A32-4BB3-B653-C66098B1CE4AQ36196812-8F2A649C-FE32-461F-9F4C-0E032DBBCFF4Q37538879-2CDF94F9-4138-4DD5-8705-DAD343B9495FQ37642807-242BFDE9-E029-4BBE-BB9C-661107566F04Q37705990-58394D42-9CCE-4603-AEB4-5B70C1B99DF8Q38030991-98FA89EE-3A64-4332-A540-44E1CAAA5667Q38132175-BA8C97B3-8036-4636-BEE5-259F286F0FCBQ38450989-D4C4DFA2-D9EE-4ABA-84CE-D16819298905Q40060996-75C27988-EDC5-4F5F-A7FE-5AD802568FCAQ40922247-1C6CC4C9-C3DC-4C56-A425-3580C4D94A0AQ47095119-5B1F95C2-1A5A-442D-ADD9-A79826E614C3
P2860
Hepatocarcinogenesis and ceramide/cholesterol metabolism.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hepatocarcinogenesis and ceramide/cholesterol metabolism.
@en
Hepatocarcinogenesis and ceramide/cholesterol metabolism.
@nl
type
label
Hepatocarcinogenesis and ceramide/cholesterol metabolism.
@en
Hepatocarcinogenesis and ceramide/cholesterol metabolism.
@nl
prefLabel
Hepatocarcinogenesis and ceramide/cholesterol metabolism.
@en
Hepatocarcinogenesis and ceramide/cholesterol metabolism.
@nl
P2093
P1476
Hepatocarcinogenesis and ceramide/cholesterol metabolism.
@en
P2093
Albert Morales
Carmen Garcia-Ruiz
Jose C Fernandez-Checa
P304
P356
10.2174/187152012800228689
P577
2012-05-01T00:00:00Z